|
1
|
Diverio D, Lo Coco F, D'Adamo F, et al:
Identification of DNA rearrangements at the retinoic acid
receptor-alpha (RAR-alpha) locus in all patients with acute
promyelocytic leukemia (APL) and mapping of APL breakpoints within
the RAR-alpha second intron. Blood. 79:3331–3336. 1992.PubMed/NCBI
|
|
2
|
Yamanouchi J, Hato T, Niiya T, et al: A
new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute
promyelocytic leukemia. Int J Hematol. 94:395–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rowley JD, Golomb HM and Dougherty C:
15/17 translocation, a consistent chromosomal change in acute
promyelocytic leukaemia. Lancet. 1:549–550. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Thé H, Chomienne C, Lanotte M, Degos L
and Dejean A: The t(15;17) translocation of acute promyelocytic
leukaemia fuses the retinoic acid receptor alpha gene to a novel
transcribed locus. Nature. 347:558–561. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Campbell LJ, Oei P, Brookwell R, et al:
FISH detection of PML-RARA fusion in ins(15;17) acute promyelocytic
leukemia depends on probe size. Biomed Res Int. 2013:1645012013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rizzatti EG, Portieres FL, Martins SL,
Rego EM, Zago MA and Falcão RP: Microgranular and
t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia
also present the flow cytometric pattern of CD13, CD34 and CD15
expression characteristic of PML-RARalpha gene rearrangement. Am J
Hematol. 76:44–51. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Redner RL: Variations on a theme: The
alternate translocations in APL. Leukemia. 16:1927–1932. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng L, Xue Y, Li J, et al: Application
of metaphase-fluorescence in situ hybridization to the diagnosis of
acute promyelocytic leukemia and the detection of minimal residual
disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 8:180–184. 2000.(In
Chinese). PubMed/NCBI
|
|
9
|
Gallagher RE, Li YP, Rao S, et al:
Characterization of acute promyelocytic leukemia cases with PML-RAR
alpha break/fusion sites in PML exon 6: Identification of a
subgroup with decreased in vitro responsiveness to all-trans
retinoic acid. Blood. 86:1540–1547. 1995.PubMed/NCBI
|
|
10
|
Avvisati G, Lo Coco F and Mandelli F:
Acute promyelocytic leukemia: Clinical and morphologic features and
prognostic factors. Semin Hematol. 38:4–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guglielmi C, Martelli MP, Diverio D, et
al: Immunophenotype of adult and childhood acute promyelocytic
leukaemia: Correlation with morphology, type of PML gene breakpoint
and clinical outcome. A cooperative Italian study on 196 cases. Br
J Haematol. 102:1035–1041. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tallman MS, Kim HT, Montesinos P, et al:
Does microgranular variant morphology of acute promyelocytic
leukemia independently predict a less favorable outcome compared
with classical M3 APL? A joint study of the North American
Intergroup and the PETHEMA Group. Blood. 116:5650–5659. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshii M, Ishida M, Yoshida T, et al:
Clinicopathological features of acute promyelocytic leukemia: An
experience in one institute emphasizing the morphological and
immunophenotypic changes at the time of relapse. Int J Clin Exp
Pathol. 6:2192–2198. 2013.PubMed/NCBI
|
|
14
|
Invernizzi R, Iannone AM, Bernuzzi S, et
al: Acute promyelocytic leukemia: Morphological and clinical
features. Haematologica. 78:156–161. 1993.PubMed/NCBI
|
|
15
|
Fang J, Chen SJ, Tong JH, Wang ZG, Chen GQ
and Chen Z: Treatment of acute promyelocytic leukemia with ATRA and
As2 O3: A model of molecular target-based
cancer therapy. Cancer Biol Ther. 1:614–620. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim MJ, Cho SY, Lim G, et al: A rare case
of microgranular acute promyelocytic leukemia associated with
ider(17)(q10)t(15;17) in an old-age patient. Korean J Lab Med.
31:86–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang H, Liu ZF and Pan JL: The clinical
and experimental research of 2 cases of acute promyelocytic
leukemia with atypical t(15;17) translocation. Guo Ji Shu Xue Ji
Xue Ye Xue Za Zhi. 35:315–317. 2012.(In Chinese).
|
|
18
|
Kurian S, Hogan TF, Bleigh OC, Dowdy YG,
Merghoub T, Pandolfi PP and Wenger SL: Atypical t(15;17)(q13;q12)
in a patient with all-trans retinoic acid refractory secondary
acute promyelocytic leukemia: A case report and review of the
literature. Cancer Genet Cytogenet. 138:143–148. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen SN, Xue YQ, Wu YF and Pan JL:
Cytogenetic and molecular genetic studies on a variant of t(15;17),
ins(17;15)(q21;q14q22), in an acute promyelocytic leukemia patient.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 21:77–79. 2004.(In Chinese).
PubMed/NCBI
|
|
20
|
Grimwade D, Gorman P, Duprez E, et al:
Characterization of cryptic rearrangements and variant
translocations in acute promyelocytic leukemia. Blood.
90:4876–4885. 1997.PubMed/NCBI
|
|
21
|
Grimwade D, Biondi A, Mozziconacci MJ, et
al: Characterization of acute promyelocytic leukemia cases lacking
the classic t(15;17): Results of the European Working Party. Groupe
Français de Cytogénétique Hématologique, Groupe de Français
d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1
European Community-Concerted Action ‘Molecular Cytogenetic
Diagnosis in Haematological Malignancies’. Blood. 96:1297–1308.
2000.PubMed/NCBI
|
|
22
|
Haimi M, Elhasid R, Weyl Ben-Arush M,
Brill-Zamir R, Laevski I and Gershoni-Baruch R: Derivative
(7)t(7;8)(q34;q21): An additional chromosome aberration in acute
promyelocytic leukemia-prognostic influence debated. Cancer Genet
Cytogenet. 153:81–83. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cervera J, Montesinos P, Hernández-Rivas
JM, et al: Additional chromosome abnormalities in patients with
acute promyelocytic leukemia treated with all-trans retinoic acid
and chemotherapy. Haematologica. 95:424–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan TS, Ma SK, Au WY, Liu HS, Chan JC and
Chan LC: Trisomy 21 and other chromosomal abnormalities in acute
promyelocytic leukemia. Cancer Genet Cytogenet. 140:170–173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bastos EF, Silva LA, Ramos MC, et al:
Trisomy 11 as an additional chromosome alteration in a child with
acute promyelocytic leukemia with poor prognosis. Case Rep Genet.
2012:6590162012.PubMed/NCBI
|
|
26
|
Xue Y, Lu D, Yuan YZ, Guo Y and Xie X: A
rare variant translocation t(3;8)(q29;q22) without AML1/ETO fusion
transcript in a case of oligoblastic leukemia. Leuk Res.
22:1015–1019. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hasle H, Alonzo TA, Auvrignon A, et al:
Monosomy 7 and deletion 7q in children and adolescents with acute
myeloid leukemia: An international retrospective study. Blood.
109:4641–4647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spell DW, Velagaleti GV, Jones DV and
Velasquez WS: Translocation (15;17) and trisomy 21 in the
microgranular variant of acute promyelocytic leukemia. Cancer Genet
Cytogenet. 132:74–76. 2002. View Article : Google Scholar : PubMed/NCBI
|
